Tag: Lenacapavir
-
Lenacapavir Agreement to Revolutionize HIV Prevention in LMICs
Lenacapavir: A Game-Changer in HIV Prevention On September 24, 2025, an unprecedented partnership was announced that promises to transform HIV prevention in low- and middle-income countries (LMICs). Dr. Reddy’s Laboratories has entered into a landmark agreement with Unitaid, the Clinton Health Access Initiative (CHAI), and Wits RHI to make the injectable HIV prevention tool lenacapavir…
-
Lenacapavir Agreement: A Breakthrough in HIV Prevention
Introduction to Lenacapavir In a groundbreaking development for global health, a new injectable HIV prevention tool, lenacapavir, is set to be available at an astonishingly low price of just US$40 per year in 120 low- and middle-income countries (LMICs). This significant milestone comes as part of a landmark agreement announced on September 24, 2025, involving…
-
Revolutionary HIV Prevention: Lenacapavir Made Affordable
Introduction to Lenacapavir On September 24, 2025, a landmark agreement was reached to bring the groundbreaking HIV prevention tool, injectable lenacapavir, to 120 low- and middle-income countries (LMICs) at an astonishing cost of just $40 per year. This partnership between Dr. Reddy’s Laboratories, Unitaid, the Clinton Health Access Initiative (CHAI), and Wits RHI marks a…